Is monitoring anti-Xa levels necessary in pregnant women on therapeutic low molecular weight heparin (LMWH)?

被引：1
|
作者：
Temming, Lorene A. [1 ]
Young, Omar M. [1 ]
Stout, Molly J. [1 ]
Tuuli, Methodius G. [1 ]
Macones, George A. [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2016年 / 214卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2015.10.308
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
269
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [1] Anti-Xa monitoring is required in pregnant women on low molecular weight heparin (LMWH)
    Simpson, V. M. A.
    Pescott, M.
    Peebles, D.
    Cohen, H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1060 - 1060
  • [2] Low-molecular weight heparin (LMWH) in pregnancy: Role of anti-Xa monitoring
    Abu-Hajir, M
    Kuhlmann, RS
    Wigton, TR
    Friedman, KD
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 846 - 846
  • [3] Low molecular weight heparin (LMWH) and anti-Xa monitoring in pregnancy. A single centre experience
    Shah, V.
    Waddilove, C.
    Roughley, C.
    Evans, G.
    Elliott, K.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 66 - 66
  • [4] Thrombin generation test (TGT) in pregnant women at risk of thrombosis on LMWH (low molecular weight heparin): correlation with anti-Xa activity
    Adamidou, D.
    Riddell, A.
    Priest, P.
    Mughaddam, L.
    Aghighi, S.
    Gatt, A.
    Tuddenham, E. G.
    Chowdary, P.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 77 - 77
  • [5] Monitoring of low molecular weight heparin (LMWH) therapy by anti-Xa assay. a laboratory perspective using heparin specific standards
    Kotsi, P. A.
    Chanos, A.
    Anastasopoulou, I
    Tsoukala, C.
    Markakis, K.
    Karafoulidou, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1089 - 1089
  • [6] Monitoring of Anti-Xa in Pregnant Patients with Mechanical Prosthetic Valves Receiving Low Molecular Weight Heparin: Peak or Trough Levels?
    John, Fan
    Goland, Sorel
    Khatri, Nudrat
    Elkayam, Uri
    [J]. CIRCULATION, 2010, 122 (21)
  • [7] Evaluation of the Hepcon HMS vs low-molecular-weight heparin (LMWH) anti-Xa activity
    Mertzlufft, F
    Hansen, R
    Kuppe, H
    Koster, A
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 : 78 - 78
  • [8] Is the monitoring of anti-Xa activity necessary in pregnant women undergoing thromboprophylaxis?
    O'Connell, MP
    O'Leary, M
    MacKeogh, L
    Murphy, K
    Keane, DP
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2004, 114 (01): : 12 - 14
  • [9] Experience of treating pediatric venous thromboembolism with low molecular weight heparin (LMWH) in an institute lack of anti-Xa monitoring support
    Yang, J. Y. K.
    Wong, M. L. G.
    Chan, A. K. C.
    Li, R. C. H.
    Lee, A. C. W.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1080 - 1080
  • [10] Higher doses of low molecular weight heparin (LMWH) are needed to achieve goal Anti-Xa levels in critically ill children
    Schloemer, N. J.
    Abu-Sultaneh, S.
    Hanson, S.
    Yan, K.
    Hoffmann, R. G.
    Punzalan, R.
    Havens, P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 93 - 93
12345